Most compounds that affect sexual arousal work at the plumbing level — blood flow, vascular dilation, peripheral mechanics. PT-141 does something fundamentally different: it works through the brain. Specifically, through the melanocortin-4 receptor (MC4R) in the central nervous system, activating the neural circuitry of desire rather than the hydraulics of physical response.
That distinction made PT-141 one of the most talked-about peptides in reproductive and neurological research. Here’s how it got there, and what the published science shows.
This compound is supplied exclusively for in vitro and preclinical research. It is not intended for human consumption, therapeutic application, or diagnostic use.
The Origin Story: A Tanning Peptide’s Unexpected Side Effect
PT-141 exists because of a happy accident. In the 1990s, researchers at the University of Arizona were studying Melanotan-II (MT-II), a synthetic melanocortin agonist designed to stimulate melanogenesis (tanning). During early research, subjects reported an unexpected effect: spontaneous arousal. Not a vascular response — a central, desire-driven response.
The researchers recognized what they were seeing: melanocortin receptors in the brain — specifically MC4R — were involved in sexual arousal pathways that nobody had fully mapped. They developed PT-141 (bremelanotide) as a more selective analog, optimized for MC4R over the other melanocortin receptors responsible for tanning (MC1R).
How MC4R Drives Arousal: The Neural Pathway
The melanocortin-4 receptor is expressed throughout the CNS, with high concentrations in the hypothalamus, medial preoptic area, and paraventricular nucleus — brain regions that regulate sexual behavior, energy homeostasis, and autonomic function. When PT-141 activates MC4R in these regions, the downstream signaling cascade includes:
- Dopaminergic pathway activation — increased dopamine signaling in the mesolimbic reward circuit. Dopamine is the neurotransmitter of wanting and motivation, not just pleasure.
- Oxytocin release — from the paraventricular nucleus, contributing to the arousal and bonding response.
- Hypothalamic integration — PT-141 activates circuits that coordinate the psychological experience of arousal with the physiological response, rather than bypassing the brain entirely.
This is fundamentally different from PDE5 inhibitors, which work at the vascular level and have no effect on desire. PT-141 activates desire circuitry → which then drives the physiological response. Brain-first, not body-first.
Key Preclinical Findings
Structure-Activity Relationships
PT-141 is a cyclic heptapeptide — the His-Phe-Arg-Trp core that drives melanocortin receptor activation was identified through systematic modification of the α-MSH sequence. The cyclic structure improves metabolic stability (resistance to enzymatic breakdown) and selectivity for MC4R over MC1R/MC3R/MC5R. Compared to Melanotan-II, PT-141 was designed to reduce the tanning and appetite effects while preserving the CNS-mediated arousal response.
Animal Models of Sexual Behavior
Martin et al. and colleagues published studies showing that MC4R agonism stimulated sexual behavior in rodent models — both male and female. The effects were blocked by MC4R antagonists, confirming that the melanocortin pathway was the mediator. Importantly, the response was observed even in models with impaired vascular function, reinforcing that the mechanism is central (brain) rather than peripheral (blood flow).
Beyond Arousal: MC4R Has Other Jobs
MC4R isn’t exclusively a sexual arousal receptor — it’s deeply involved in energy homeostasis and appetite regulation. MC4R knockout mice are severely obese. This metabolic role means PT-141 research intersects with metabolism research, and some studies have explored whether melanocortin agonists could serve dual purposes. The challenge is separating the arousal, metabolic, and cardiovascular effects into clinically useful profiles.
Where It Stands as a Research Tool
PT-141 occupies a unique position in peptide research: it’s the primary tool for studying melanocortin-mediated sexual arousal — a pathway that was barely understood before MT-II’s accidental discovery. For researchers investigating:
- MC4R pharmacology and signaling
- Central vs. peripheral mechanisms of sexual response
- Dopamine-oxytocin interactions in arousal circuitry
- Melanocortin system cross-talk between sexual and metabolic regulation
…PT-141 remains the go-to research compound.
Product Specifications
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Molecular Weight: 1,025.18 g/mol
- CAS Number: 189691-06-3
- Physical Form: Sterile lyophilized white powder
- Purity: ≥99% (verified by HPLC)
- Solubility: Freely soluble in bacteriostatic water
Key References
- Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930.
- Martin WJ, et al. Pharmacological profile of a novel melanocortin receptor agonist. Eur J Pharmacol. 2002.
- Molinoff PB, et al. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann NY Acad Sci. 2003.
Browse PT-141 10mg with verified COA from Janoshik Analytical. For the parent compound, see Melanotan II. Explore our Sexual Health Research category.